Preterm Immune System Development and Response to Immunization

NCT05266664 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 145

Last updated 2024-03-20

No results posted yet for this study

Summary

In this study the response to vaccination and development of the immune system in very preterm infants upon the current vaccination schedule will be compared to healthy term infants.

Conditions

  • Immune System Disorder
  • Preterm
  • Vaccination Failure

Sponsors & Collaborators

  • Medical Center Haaglanden

    collaborator OTHER
  • Amphia Hospital

    collaborator OTHER
  • Albert Schweitzer Hospital

    collaborator OTHER
  • Franciscus Gasthuis

    collaborator OTHER
  • Maasstad Hospital

    collaborator OTHER
  • Maxima Medical Center

    collaborator OTHER
  • Reinier de Graaf Groep

    collaborator OTHER
  • Erasmus Medical Center

    collaborator OTHER
  • Merck Sharp & Dohme LLC

    collaborator INDUSTRY
  • Zuyderland Medical Centre

    collaborator OTHER
  • Haga Hospital

    collaborator OTHER
  • Maastricht University Medical Center

    lead OTHER

Principal Investigators

  • Gertjan Driessen, Prof MD PhD · Maastricht UMC

  • Jantien Bolt-Wieringa, MD · Medical Center Haaglanden

Eligibility

Min Age
1 Day
Max Age
2 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-12-08
Primary Completion
2025-07-31
Completion
2026-07-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05266664 on ClinicalTrials.gov